Patents by Inventor Stefan Sanczuk

Stefan Sanczuk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4225606
    Abstract: Novel N-aryl-N-(1-L-4-piperidinyl)arylacetamides useful as antiarrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: September 30, 1980
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Stefan Sanczuk, Hubert K. F. Hermans
  • Patent number: 4208418
    Abstract: Novel N-aryl-N-(1-L-4-piperidinyl)arylacetamides useful as anti-arrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: June 17, 1980
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Stefan Sanczuk, Hubert K. Fr. Hermans
  • Patent number: 4198411
    Abstract: Novel N-aryl-N-(1-L-4-piperidinyl)arylacetamides useful as antiarrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: April 15, 1980
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Stefan Sanczuk, Hubert K. F. Hermans
  • Patent number: 4197304
    Abstract: Novel N-aryl-N-(1-L-4-piperidinyl)arylacetamides useful as anti-arrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: April 8, 1980
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Stefan Sanczuk, Hubert K. F. Hermans
  • Patent number: 4197303
    Abstract: Novel N-aryl-N-(1-L-4-piperidinyl)arylacetamides useful as anti-arrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: April 8, 1980
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Stefan Sanczuk, Hubert K. F. Hermans
  • Patent number: 4196210
    Abstract: Novel N-aryl-N-(1-L-4-piperidinyl)arylacetamides useful as anti-arrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: April 1, 1980
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Stefan Sanczuk, Hubert K. Fr. Hermans
  • Patent number: 4157393
    Abstract: Novel N-aryl-N-(1-L-4-piperidinyl)arylacetamides useful as antiarrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: June 5, 1979
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Stefan Sanczuk, Hubert K. Fr. Hermans
  • Patent number: 4151286
    Abstract: Novel N-aryl-N-(1-L-4-piperidinyl)-arylacetamides useful as antiarrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
    Type: Grant
    Filed: July 13, 1978
    Date of Patent: April 24, 1979
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Stefan Sanczuk, Hubert K. Fr. Hermans
  • Patent number: 4126689
    Abstract: Novel N-aryl-N-(1-L-4-piperidinyl)arylacetamides useful as antiarrhythmic agents, a method of treating arrhythmia which comprises the systemic administration of such compounds to warm-blooded animals and pharmaceutical compositions to be used therefor.
    Type: Grant
    Filed: May 11, 1977
    Date of Patent: November 21, 1978
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Stefan Sanczuk, Hubert K. F. Hermans